One look at a Chinese Drug company and who their large outsources clients are here in the US…names we all recognize too. Add the 3 numbers up and you come up with around 38% of their business from the 3 companies. The number of blockbuster drugs going off patent along with the rising...
Interview with a company that has settled in Bejiing, China explains why...cost is one issue coming in at one third the amount required here in the United States...and another is the availability of scientists...we all think cost is the only area that drives business overseas, but this is another added...